US 8501188
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
granted A61PA61P11/00A61P11/08
Quick answer
US patent 8501188 (Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P11/00, A61P11/08, A61P11/10, A61P29/00